You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指跌28點 阿裏巴巴回吐5% 藥明生物升逾6%
美股昨日(7日)在晶片股帶動下造好,納指升3%,道指亦漲492點或1.4%,港股昨日急升後,今早表現反覆。恆指高開106點後,在23,900點至24,100點之間爭持,半日跌28點或0.12%,報23,954點;國指跌16點或0.19%,報8,510點;恆生科技指數跌不足1點或不足0.01%,報5,969點。大市半日成交總額縮減至672.03億元,滬、深港通南下交易半日分別淨流入13億及8.28億元人民幣。 中概股迴流股份方面,阿裏巴巴(09988.HK)回吐5.1%報120元,網易(09999.HK)回吐2.9%報165.6元,百度(09888.HK)跌1.1%,汽車之家(02518.HK)升2.8%。微博(09898.HK)首日在港第二上市,半日收報254.2元,較上市價272.8元低6.8%。 其他科技股方面,騰訊(00700.HK)升0.6%報466.8元,小米(01810.HK)跌0.3%報19.18元,美團(03690.HK)升0.3%報246.6元。京東健康(06618.HK)及金蝶(00268.HK)各升3.2%及3.6%。大摩上調蘋果目標價,蘋果股價創新高,手機相關股造好。舜宇(02382.HK)升3.4%,比亞迪電子(00285.HK)升5.5%,丘鈦(01478.HK)升2.5%。 融創(01918.HK)再減持貝殼股份套現5.3億美元,料錄交易稅前虧損逾56億人民幣,股價跌2.7%。其餘內房股普遍回落,奧園(03883.HK)及世茂(00813.HK)各跌5.9%及4.5%。評級機構標普指恆大(03333.HK)違約恐無法避免,恆大跌1.6%,同系恆大物業(06666.HK)及恆大汽車(00708.HK)各跌2.5%及5.5%。佳兆業(01638.HK)停牌,同系佳兆業美好(02168.HK)跌1.7%,佳兆業資本(00936.HK)跌11.6%。 醫藥股方面,野村首次覆蓋18家內地醫藥公司,首選中生製藥(1177.HK)、藥明生物(02269.HK)及信達生物(01801.HK)等,中生製藥及藥明生物各升2.9%及6.2%,信達生物升1.4%。據報內地青島港及日照港計劃調整裝卸業務收費,青島港(06198.HK)股價未受刺激,半日跌0.2%。航運股東方海外(00316.HK)及中遠海控(01919.HK)則升4%及2.8%。 電力股受捧,華能國電(00902.HK)升8.4%,大唐發電(00991.HK)及中國電力(02380.HK)各升3.9%及4.9%。資源股江銅(00358.HK)、贛鋒鋰業(01772.HK)及中鋁(02600.HK)各升逾3%。 其他藍籌方面,匯控(00005.HK)跌0.7%報45.35元,港交所(00388.HK)跌0.5%報470.4元,友邦(01299.HK)升0.7%報82.65元,李寧(02331.HK)升5.2%報92元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account